脂质纳米粒子配方用于基因编辑和基于RNA的治疗质母细胞瘤
Yanhong Zhang1, Rosalia Rabinovsky1, Evgeny Deforzh1
1Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115 USA.
Neuro-oncology
|July 14, 2025
概括
提供CRISPR-Cas9基因编辑系统的脂质纳米颗粒有效地向并抑制质母细胞瘤中的microRNA-10b. 这种新型疗法miRTEN在治疗这种致命癌症方面表现有前途,即使与化疗相结合.
科学领域:
- 神经瘤学神经瘤学
- 基因治疗 基因治疗
- 纳米医学是一种纳米医学.
背景情况:
- 质母细胞瘤 (GBM) 是一种高度异质和致命的脑癌,治疗选择有限.
- 微RNA-10b (miR-10b) 是质瘤生长的关键驱动因素,也是潜在的治疗点.
- 为GBM治疗提供有效的基因编辑系统仍然是一个重大挑战.
研究的目的:
- 开发和评估一种新的基于脂质纳米粒子 (LNP) 的系统,用于在GBM中针对性编辑miR-10b的基因.
- 在临床前的GBM模型中评估该系统的治疗疗效,免疫反应和安全性.
主要方法:
- 开发了miRTEN,封装Cas9mRNA的LNP和一个针对miR-10b的sgRNA.
- 在质瘤干细胞 (GSCs) 和通过脑内静脉注射 (ICV) 测试 orthotopic GBM 模型中的 miRTEN.
- 治疗效果,免疫激活和安全性概况的评估.
主要成果:
- miRTEN在GBM瘤中实现了广泛而持久的miR-10b基因编辑,显著抑制了瘤生长和GSC活力.
- 使用miRTEN和temozolomide (TMZ) 的联合治疗克服了耐药性并改善了生存率.
- miRTEN激活了抗瘤免疫力,增强了CD8+ T细胞的透,并证明了 GBM 特定的向,具有最小的非向毒性.
结论:
- 以LNP为媒介的CRISPR-Cas9系统为GBM中针对性的miR-10b编辑提供了一个可行的策略.
- miRTEN 代表了一种有前途,安全和有效的GBM治疗方法,无论是单独治疗还是与标准治疗相结合.
- 这项技术有可能在基因编辑和脑癌的RNA疗法中得到更广泛的应用.
相关概念视频
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K


